Page results
-
Information about endovascular treatments of AVMs undertaken in the NHNN angiography suite.
-
Information about coil embolisations and how endovascular treatment is used to treat cerebral aneurysms.
-
Information for patients from overseas visiting UCLH hospitals.
-
Health secretary Matt Hancock visited University College Hospital yesterday to see for himself our post-Covid-19 service set up to help survivors of the virus with their long-term recovery.
-
Ensuring that UCLH staff understand the urgency of the climate crisis and support our net zero programme is crucial if we want to be successful in reaching our goal of net zero carbon emissions by 2031. Our patients must be kept informed of changes and we must work closely with other NHS organisations, including NHS England, if we are to deliver a successful programme. This page documents our progress to date.
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
Information on how we ask for your consent to treatment, and Martha's Rule.
-
Lizzi Jordan, who received life-saving treatment at UCLH before going on to win a gold medal for cycling in the 2024 Paralympic Games, paid tribute to UCLH staff as she was made a Member of the British Empire (MBE).
-
Medtronic are discontinuing the MiniMed™ Mio™ Infusion sets. If you are currently using MiniMed™ Mio™ infusion sets, you will need to change to an alternative infusion set before 31 March 2023. After this date, MiniMed™ Mio™ infusion sets will no longer be available.
-
SUMMIT Study results on the benefits of large-scale screening for lung cancer are published in The Lancet Oncology today (26 March), ahead of the formal addition of lung cancer screening to the UK national screening programme from 1 April.
File results
-
FOI/2021/0714 - Data management systems of care testing devices
-
FOI/2021/0715 - Urothelial cancer treatment
-
FOI/2021/0716 - COVID-19 deaths
-
FOI/2021/0721 - Maternity units within your trust
-
FOI/2021/0723 - Covid 19 deaths
-
FOI/2021/0730 - Treatment with Ofatumumab
-
FOI/2021/0736 - Prehabilitation
-
FOI/2021/0737 - Health information systems
-
FOI/2021/0710 - Patient safety incidents resulting in severe harm or death
-
FOI/2021/0732 - Policy for maternity partners